Pim-1 is an oncogenic serine/threonine kinase implicated in cytokine-induced signal transduction and in development of lymphoid malignancies. However, its precise function as well as physiological substrates have remained unknown. In this study we demonstrate that Pim-1 can physically interact with the NFATc1 transcription factor and phosphorylate it in vitro on several serine residues. In contrast to previously recognized NFATc kinases, wild-type Pim-1 enhances NFATc-dependent transactivation and IL-2 production in Jurkat T cells, while kinase-deficient Pim-1 mutants inhibit them in a dominant negative fashion. Our results reveal a novel, phosphorylation-dependent regulatory mechanism targeting NFATc1 through which Pim-1 acts as a downstream effector of Ras to facilitate IL-2-dependent proliferation and/or survival of lymphoid cells.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Rainio, E.-M., Sandholm, J., & Koskinen, P. J. (2002). Cutting Edge: Transcriptional Activity of NFATc1 Is Enhanced by the Pim-1 Kinase. The Journal of Immunology, 168(4), 1524–1527. https://doi.org/10.4049/jimmunol.168.4.1524